Your browser doesn't support javascript.
loading
"How Much Time Do I Have?": Communicating Prognosis in the Era of Exceptional Responders.
LeBlanc, Thomas W; Temel, Jennifer S; Helft, Paul R.
Afiliación
  • LeBlanc TW; From the Cancer Patient Experience Research Program, Duke Cancer Institute, Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC; Massachusetts General Hospital, Boston, MA; Department of Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN.
  • Temel JS; From the Cancer Patient Experience Research Program, Duke Cancer Institute, Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC; Massachusetts General Hospital, Boston, MA; Department of Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN.
  • Helft PR; From the Cancer Patient Experience Research Program, Duke Cancer Institute, Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC; Massachusetts General Hospital, Boston, MA; Department of Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN.
Am Soc Clin Oncol Educ Book ; 38: 787-794, 2018 May 23.
Article en En | MEDLINE | ID: mdl-30231384
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Relaciones Médico-Paciente / Comunicación / Supervivientes de Cáncer Tipo de estudio: Prognostic_studies Idioma: En Revista: Am Soc Clin Oncol Educ Book Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Relaciones Médico-Paciente / Comunicación / Supervivientes de Cáncer Tipo de estudio: Prognostic_studies Idioma: En Revista: Am Soc Clin Oncol Educ Book Año: 2018 Tipo del documento: Article